U.S. P2Y12 Inhibitors Market Poised to Grow at a High CAGR Owing to Rising Cardiovascular Diseases Prevalence

 
U.S. P2Y12 Inhibitors Marke

The U.S. P2Y12 inhibitors market comprises drugs that inhibit the binding of adenosine diphosphate (ADP) to its platelet P2Y12 receptor, preventing activation and aggregation of platelets. P2Y12 inhibitors are commonly used as antiplatelet agents after coronary stent placement or acute coronary syndromes to prevent thrombotic complications. These drugs play a vital role in managing cardiovascular diseases including myocardial infarction, unstable angina, and ischemic stroke. The increasing prevalence of cardiovascular diseases and growing number of cardiac procedures in the country are driving the demand for P2Y12 inhibitors in the United States.


The Global U.S. P2Y12 inhibitors Market is estimated to be valued at US$ 267.73 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the U.S. P2Y12 inhibitors are Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation. Major players are focusing on new product launches and expansion of manufacturing facilities to strengthen their market position.

The key opportunities in the market include increasing adoption of biosimilars and novel oral antiplatelets. Biosimilar drugs provide cost-effective treatment options compared to reference biologics, thereby positively impacting the market growth.

Geographically, North America dominates the global U.S. P2Y12 Inhibitors Market Size  and is expected to continue its dominance over the forecast period. However, Asia Pacific is anticipated to exhibit the highest growth rate owing to the rising healthcare expenditure and increasing focus of major players in developing countries.

Market drivers

The major driver for the U.S. P2Y12 inhibitors market is the rapidly growing geriatric population. As age increases the risks of developing heart diseases also increases significantly. According to the United Nations, United States is home to one of the largest population of older persons aged 65 years or over. It is estimated that by 2050, 1 in 4 Americans will be aged 65 and over. This growing pool of elderly individuals will augment the demand for cardiovascular drugs including P2Y12 inhibitors in the country.

PEST Analysis
Political: The regulations pertaining to the approval of new drugs and medical devices are quite stringent in the US. Any changes in the regulatory environment could impact the market either positively or negatively.
Economic: The US has one of the biggest healthcare markets globally. Changes in the overall economy and healthcare spending can have a substantial impact on the growth of the P2Y12 inhibitors market.
Social: With rising ageing population and chronic diseases prevalence, there is growing awareness about heart diseases and treatment options available. This is creating more demand for antiplatelet drugs like P2Y12 inhibitors.
Technological: Advancements in drug delivery mechanisms and development of novel formulations for improving efficacy are expanding therapeutic applications of P2Y12 inhibitors. Combination therapies with other anticoagulants is also an area of active research.

The highest value concentration for the U.S. P2Y12 inhibitors market is in regions with large population bases like California, Texas, Florida and New York. These states contribute significantly to the national healthcare expenditures. Western and Northeastern parts of the country account for over 60% share of the total market value.

The Midwestern region of the US, comprising states like Illinois, Ohio, Michigan, Indiana, Wisconsin and Minnesota, is projected to witness the fastest growth in the P2Y12 inhibitors market during the forecast period. This is attributed to rising prevalence of cardiovascular ailments in the middle-aged demographic and growing healthcare insurance coverage in this region. Additionally, several pharmaceutical companies focusing on cardiovascular drugs have production and R&D facilities located here, enhancing product accessibility.

Comments

Post a Comment

Popular posts from this blog

Eyewear Market Is Estimated To Witness High Growth Owing To the Growing Demand for Prescription Eyewear

Image
  Eyewear Market The global Eyewear Market is estimated to be valued at US$ 273.4 billion in 2018 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023-2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: The Eyewear Market includes products such as prescription glasses, contact lenses, and sunglasses. These products offer vision correction and protection from harmful ultraviolet (UV) rays. The increasing prevalence of eye disorders and the growing awareness about the importance of eye health are driving the demand for eyewear products. Furthermore, the rising use of digital devices and exposure to blue light is also contributing to the need for prescription eyewear to reduce eye strain and prevent vision problems. Market Key Trends: One key trend in the Eyewear Market is the increasing demand for fashionable and luxury eyewear. Consumers are not only seeking vision correction but also looking for eyewear that complements
Read more

The Mobile Computed Tomography Is The Fastest Growing Segment Fueling The Growth Of Computed Tomography Market

Image
  Computed Tomography Market The global Computed Tomography Market is estimated to be valued at US$ 7.9 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview : Computed tomography, commonly known as CT or CAT scan, is a medical imaging technique used for clinical diagnosis and interventional procedures. CT imaging provides cross-sectional views of the internal organs to accurately detect medical conditions such as cancer, blood clots, lung nodules, or bone fractures. CT scans generate three-dimensional images or slices of the bones, blood vessels, and soft tissues inside the body. Market key trends: One of the key trends in the computed tomography market is the growing adoption of mobile CT systems. Mobile CT systems are CT devices that can be transported to various locations within a hospital campus or healthcare facility. Mobile CT scanners provide versat
Read more

Electronic Warfare Market Poised to Witness High Growth Owing to Increasing Usage of EW Systems Across Military and Defense Sectors

Image
Electronic Warfare Market Electronic warfare (EW) systems are used for detecting, deceiving or damaging enemy’s communication and radar systems. It involves deliberate emission or suppression of electromagnetic energy to maintain information dominance. EW systems find wide applications across military, including land, sea, air and space operations for counteracting threats from armed forces of other nations. The need for situational awareness and gaining tactical advantage over opponents has catalyzed demand from armed forces globally. The global electronic warfare market is estimated to be valued at US$ 18.45 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031.  Key players operating in the electronic warfare market are BAE Systems plc, Elbit Systems Ltd., General Dynamics Corporation, Israel Aerospace Industries Ltd., L3Harris Technologies Inc., Leonardo SpA, Lockheed Martin Corporation, Northrop Grumman Corporation, Raytheon Technologies Corpor
Read more